BioconBCLTF

13F holders, Q3 2024 (September 30)
1holders −1
0new positions
1sold out
$4.33avg. 13F price*

At the end of Q3 2024, 1 institutions reported holding Biocon Ltd. (BCLTF) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holder was Stanley-Laman Group, Ltd. ($3.5M).

Company
Biocon Ltd.
CUSIP
Y0905C102
Latest filing quarter
Q1 2025

History

Number of 13F holders

012 Q1 2024: 2Q1 2024Q2 2024: 2Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions0$0
Exits1$2.3M

All 13F filers, Q2 2024 → Q3 2024: 549,512 shares sold, net −549,512 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Stanley-Laman Group, Ltd. 0.44% No change 800,000 $3.5M

"% of holder's portfolio" is BCLTF's weight in each manager's 13F, not the share of Biocon Ltd. the manager owns.